Exclusive: EU talks with Pfizer, Sanofi, J&J on COVID vaccines hit snags - sources

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

European efforts to secure potential COVID-19 vaccines from Pfizer, Sanofi and Johnson & Johnson are mired in wrangles over price, payment method ...

European efforts to secure potential COVID-19 vaccines from Pfizer, Sanofi and Johnson & Johnson are mired in wrangles over price, payment method and potential liability costs, three EU officials told Reuters.

The United States, meanwhile, has already inked two supply agreements with AstraZeneca and Pfizer among other major funding deals. The two firms want the EU to pay them for 500 million doses only if their COVID-19 vaccine is authorised, one official told Reuters. Pfizer and BioNtech are also discussing liability issues with EU negotiators, a fourth person familiar with the talks told Reuters.The U.S. government last week agreed to pay nearly US$2 billion to buy enough of the vaccine being developed by Pfizer and BioNTech to inoculate 50 million people, but with payments conditional on their vaccine being successful in large clinical trials.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

ST Covid-19 Webinar: Experts on why vaccine is not panacea for coronavirus. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Moderna's Covid-19 vaccine candidate moves into late-stage trialMASSACHUSETTS (REUTERS) - Moderna said on Monday (July 27) that it has started a US government-backed late-stage trial for its Covid-19 vaccine candidate, the first to be implemented under the Trump administration's Operation Warp Speed anti-coronavirus programme.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Moderna's COVID-19 vaccine candidate moves into late-stage trialNews of the study, which will test the response to the vaccine in 30,000 adults who do not have the respiratory illness, pushed shares in Cambridge, Massachusetts-based Moderna up 11% at $81.31 before the bell. The federal government is supporting Moderna's vaccine project with nearly a billion
Source: YahooSG - 🏆 3. / 71 Read more »

SAP picked by Moderna to help distribute COVID-19 vaccine candidateBERLIN: Business software group SAP has been selected by Moderna to help distribute the potential COVID-19 vaccine that the U.S. pharmaceuticals ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

The Straits Times @STcomTHE BIG STORY: S'pore could start human trials for Covid-19 vaccine this week | Why are dengue cases surging here?
Source: The Straits Times - 🏆 8. / 63 Read more »

Singapore could start Covid-19 vaccine human trials this weekHuman trials for a Covid-19 vaccine could begin in Singapore as early as this week.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »